HCA Healthcare (NYSE:HCA) Releases FY 2024 Earnings Guidance

HCA Healthcare (NYSE:HCA) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 21.600-22.800 for the period, compared to the consensus earnings per share estimate of 20.980. The company issued revenue guidance of $69.8 billion-$71.8 billion, compared to the consensus revenue estimate of $69.8 billion.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HCA. Truist Financial lifted their price objective on shares of HCA Healthcare from $375.00 to $390.00 and gave the stock a buy rating in a report on Wednesday. TD Cowen decreased their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a buy rating for the company in a research note on Tuesday, April 30th. Oppenheimer boosted their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an outperform rating in a research note on Wednesday. Baird R W upgraded shares of HCA Healthcare to a strong-buy rating in a research note on Thursday, May 30th. Finally, Cantor Fitzgerald reiterated an overweight rating and issued a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of Moderate Buy and a consensus price target of $339.72.

HCA Healthcare Trading Up 2.6 %

Shares of HCA opened at $352.79 on Friday. The stock has a market capitalization of $92.40 billion, a P/E ratio of 17.59, a PEG ratio of 1.38 and a beta of 1.68. The company has a quick ratio of 1.02, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $356.30. The firm has a fifty day simple moving average of $329.48 and a two-hundred day simple moving average of $322.74.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.29 earnings per share. On average, research analysts anticipate that HCA Healthcare will post 22.38 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.75%. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Michael S. Cuffe sold 6,311 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the transaction, the executive vice president now directly owns 29,624 shares in the company, valued at $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 12,397 shares of company stock valued at $3,921,929. 1.60% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.